Cleared Traditional

K811397 - ECA

K811397 is an FDA 510(k) clearance for ECA, manufactured by Gillco, Inc.. The device is a Class 1 General Hospital device with product code FOA cleared through the Traditional 510(k) pathway after a 45-day FDA review.

K811397 · Gillco, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1981
Decision
45d
Days
Class 1
Risk

K811397 is an FDA 510(k) clearance for the ECA. Classified as Board, Cardiopulmonary (product code FOA), Class I - General Controls.

Submitted by Gillco, Inc. (Walker, US). The FDA issued a Cleared decision on July 2, 1981 after a review of 45 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6080 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Gillco, Inc. devices

FDA 510(k) Submission Details - K811397

510(k) Number K811397 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 1981
Decision Date July 02, 1981
Days to Decision 45 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 129d · This submission: 45d
Pathway characteristics
Predicate-based equivalence.

FOA Device Classification - Class 1, General Controls

Product Code FOA Board, Cardiopulmonary
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 880.6080
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.